This article is part of the supplement: 25th European Workshop for Rheumatology Research
Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
Arthritis Research & Therapy 2005, 7(Suppl 1):P46 doi:10.1186/ar1567
No comments have yet been made on this article.
